Syncona Portfolio Ltd
- SEC CIK
- 0001725042
- Latest filing
- Aug 6, 2026
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 4, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 4
- 0 vs. Q2 2022
- Portfolio value
- $57.5M
- −$12.8M (−18.2%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 11,086,909 | $25.1M | 43.5% | 00.0% | Unchanged | – |
| AUTLAutolus Therapeutics plc | SPON ADS | 7,346,829 | $15.7M | 27.3% | 00.0% | Unchanged | History |
| Freeline Therapeutics Hldgs35655L107 | SPONSORED ADS | 21,997,620 | $15.3M | 26.6% | 00.0% | Unchanged | – |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 1,377,294 | $1.48M | 2.6% | 00.0% | Unchanged | History |